Doxil — The First FDA-Approved Nano-Drug: From an Idea to a Product - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 392

Goren, D., Liposomes as doxorubicin carriers: a means to improve the
therapeutic index of the drug, Ph.D. thesis submitted and approved by
the Hebrew University of Jerusalem (1990).
Goren, D., Gabizon, A., and Barenholz, Y., The influence of physical
characteristics of liposomes containing doxorubicin on their
pharmacological behavior, Biochim. Biophys. Acta , 1029 , 285-294
(1990).
Gabizon, A., Isacson, R., Rosengarten, O., Tzemach, D., Shmeeda, H., and
Sapir, R., An open-label study to evaluate dose and cycle dependence
of the pharmacokinetics of pegylated liposomal doxorubicin, Cancer
Chemother. Pharmacol ., 1 (4), 695-702 (2008).
Grant, G.J., Barenholz, Y., Bansinath, M., and Davidson, E.M. A novel liposomal
Bupivacaine formulation to produce ultralong-acting analgesia,
Anesthesiology , 101 , 133-137 (2004).
Grant, G.J., Barenholz, Y., Piskoun, B., Bansinath, M., Turndorf, H., and Bolotin,
E., DRV liposomal bupivacaine: preparation, characterization and in
vivo evaluation in mice, Pharm. Res. , 18 , 336-343 (2001).
Gregoriadis, G., and Senior, J., Liposomes in vivo: a relationship between
stability and clearance? In: Targeting of Drugs with Synthetic Systems
(Gregoriadis, G., Senior, J., Poste, G., eds) , London, Plenum, pp. 183-192
(1986).
Gregoriadis, G., Swain, C.P., Wills, E.J., and Tavill, A.S., Drug-carrier potential
of liposomes in cancer chemotherapy, Lancet , 1 , 1313-1316 (1974).
Gundersen, S., Kvinnsland, S., Klepp, O., Kvaloy, S., Lund, E., Host, H., Weekly
Adriamycin versus VAC in advanced breast cancer. A randomized trial,
Eur. J. Cancer Clin. Oncol. , 22, 1431-1434 (1986).
Haran, G., Cohen, R., Bar, L.K., and Barenholz, Y., Transmembrane ammonium
sulfate gradients in liposomes produce efficient and stable entrapment
of amphipathic weak bases. Biochim. Biophys. Acta 1151 , 201-215
(1993).
Hashizume, H., Baluk, P., Morikawa, S., McLean, J.W., Thurston, G., Roberge,
S., Jain, R.K., and MacDonald, D.M., Openings between defective
endothelial cells explain tumor vessel leakiness, Am. J. Pathol ., 156,
1363-1380 (2000).
Horowitz, A.T., Barenholz, Y., and Gabizon, A.A., In vitro cytotoxicity of
liposome-encapsulated doxorubicin: dependence on liposome
composition and drug release, Biochim. Biophys. Acta , 1109 , 203-209
(1992).
Hunt, C.A., and Papahadjopoulous, D.P., Method for producing liposomes in
selected size range, US patent 4,529,561 (July 16, 1985).